Having trouble accessing articles? Reset your cache.

AGS-004: Phase IIb started

Argos began a double-blind, placebo-controlled, U.S. and Canadian Phase

Read the full 93 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE